Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas

Publisher: Karger

E-ISSN: 1421-9913|69|2|95-101

ISSN: 0014-3022

Source: European Neurology, Vol.69, Iss.2, 2012-11, pp. : 95-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content